In recognition of Clinical Trials Day, the Coalition to Transform Clinical Trial Engagement (CTCTE) proudly announces the launch of the Champions for Change – Paid Time Off (PTO) Initiative, a national effort to reduce job-related barriers to clinical trial...
The Foundation for Sarcoidosis Research (FSR) is pleased to announce the appointment of four new members to its Board of Directors: John Mockovciak III, Joan Levy, PhD, John Carlin, and Molly Flick. “We are honored to welcome John, Joan, John, and Molly to the...
Foundation for Sarcoidosis Research Joins with Walgreens, Cedars-Sinai to Provide Foothill Unity with Free N95 Masks to Protect Residence Cleaning Up from the Recent Los Angeles Wildfires. As clean up continues from January’s devastating Los Angeles wildfires, the...
When exposed to wildfires and during the clean up, consider the following precautions to protect your health. Stay Indoors: When possible, minimize exposure to outdoor air by staying indoors, particularly during peak smoke periods. Use air purifiers to improve indoor...
This year marks a significant milestone for the Foundation for Sarcoidosis Research (FSR) as we celebrate our 25th anniversary! Since our incorporation on February 20, 2000, we have been dedicated to advancing research, providing patient support, and driving advocacy...
The Foundation for Sarcoidosis Research (FSR) has awarded three pilot grants in the amount of $100,000 each, to Dr. Satish Sati from the University of Pennsylvania, Dr. Claire Rice from the University of Bristol, and Dr. Shaikh Muhammad Atif from the University of...
Foundation for Sarcoidosis Research Warns of Increased Risk of Sarcoidosis from Fire and Smoke Exposure Urging Immediate Action to Prevent Future Health Consequences 9/11 First Responders Serve as a Warning for the Long-Term Health Effects of Smoke Inhalation and...
We understand that living with sarcoidosis can be challenging, and many of you are constantly seeking new treatment options. We want to share an important update regarding recently announced results from a pulmonary sarcoidosis clinical trial. Key Points: Trial...
The Foundation for Sarcoidosis Research (FSR) is proud to announce the recipients of the 2024 FSR Cardiac Sarcoidosis Grant, providing $200,000 in funding to advance groundbreaking research aimed at improving the diagnosis, management, and treatment of cardiac...
In August of 2023, the Foundation for Sarcoidosis Research (FSR) submitted a Request for Opinion Letter on Clinical Trials and the Family and Medical Leave Act (FMLA) with the U.S. Department of Labor (DOL). On November 8, 2024, FSR received a letter of clarification...
